Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hajime Koganei"'
Autor:
Seiji Ohno, Masataka Shoji, Akira Takahara, Tomoko Takeda, Munetaka Tokumasu, Satoshi Iwayama, Seinosuke Iwata, Shinichi Fujita, Masako Hagihara, Seiji Niwa, Hajime Koganei, Takashi Yamamoto, Tomoyuki Onishi, Yuki Saitou
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:3639-3642
A structure–activity relationship study of 6-unsubstituted-1,4-dihydropyridine and 2,6-unsubstituted-1,4-dihydropyridine derivatives was conducted in an attempt to discover N-type calcium channel blockers that were highly selective over L-type calc
Autor:
Shinichi Fujita, Seiji Ohno, Seiji Niwa, Hajime Koganei, Yuki Saitou, Seinosuke Iwata, Akira Takahara, Tomoko Takeda, Tomoyuki Onishi, Takashi Yamamoto, Munetaka Tokumasu, Chika Nakanishi, Morikazu Kito, Akira Nakajo, Yukitsugu Ono, Masataka Shoji, Yoko Masuzawa
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:4813-4816
In order to find an injectable and selective N-type calcium channel blocker, we have performed the structure-activity relationship (SAR) study on the 2-, 5-, and 6-position of 1,4-dihydropyridine-3-carboxylate derivative APJ2708 (2), which is a deriv
Autor:
Akira Takahara, Seiji Ohno, Hiroyuki Matsueda, Hisayuki Uneyama, Masataka Shoji, Shinichi Fujita, Tomoko Takeda, Seinosuke Iwata, Tomoyuki Onishi, Seiji Niwa, Morikazu Kito, Hajime Koganei, Yuki Saitou, Yukitsugu Ono, Takashi Yamamoto
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 16:798-802
Cilnidipine is a 1,4-dihydropyridine derived L/N-type calcium channel dual blocker possessing neuroprotective and analgesic effects which are related to its N-type calcium channel inhibitory activity. In order to find specific N-type calcium channel
Antisympathetic and hemodynamic property of a dual L/N-type Ca2+ channel blocker cilnidipine in rats
Publikováno v:
European Journal of Pharmacology. 434:43-47
The in vivo antisympathetic property of a dual L/N-type Ca(2+) channel blocker cilnidipine compared with that of typical N-type Ca(2+) channel blockers has never been clarified. We investigated the effects of the drug on a sympathetic nerve-mediated
Autor:
Seiji Ohno, Akira Takahara, Yuki Saitou, Munetaka Tokumasu, Shinichi Fujita, Seinosuke Iwata, Tomoko Takeda, Masako Hagihara, Satoshi Iwayama, Seiji Niwa, Hajime Koganei, Takashi Yamamoto, Masataka Shoji
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:3317-3319
An efficient asymmetric synthesis of 1,4-dihydropyridine derivatives is described. The key step is the stereoselective Michael addition using t-butyl ester of L-valine as a chiral auxiliary to achieve good ee (>95% for all the tested experiments) and
Autor:
Hiroshi Yamamoto, Tsukao Nishimori, Ayahito Kimura, Hideaki Kihara, Ken Hirose, Noriko Sasaki, Ryota Yoshimoto, Hajime Koganei, Masataka Shoji
Publikováno v:
Journal of Cardiovascular Pharmacology. 35:523-530
The serotonin (5-HT2A) antagonistic activities and the protective effect on laurate-induced peripheral vascular lesions of AT-1015, a novel 5-HT2 receptor antagonist, were investigated. In platelet aggregation, AT-1015 selectively inhibited in vitro
Publikováno v:
Biological and Pharmaceutical Bulletin. 18:1207-1210
The effects of yohimbine and desipramine on adrenal catecholamine (CA) release in response to splanchnic nerve stimulation (SNS) were examined in anesthetized dogs. SNS and 3 Hz produced frequency-dependent increases in epinephrine (EPI) and norepine
Publikováno v:
Biologicalpharmaceutical bulletin. 32(10)
Cilnidipine is a 1,4-dihydropyridine-derived voltage-dependent calcium channel (VDCC) blocker and suppresses N-type VDCC currents in addition to L-type VDCC currents. An earlier investigation has suggested that intrathecally injected cilnidipine prod
Autor:
Hajime Koganei, Hirotaka Wagatsuma, Tetsuya Ogawa, Shizuka Aritomi, Akira Mitsui, Tomoyuki Konda, Kosaku Nitta
Publikováno v:
Heart and vessels. 25(6)
The aims of the present study were to compare the effects of cilnidipine [L-type/N-type calcium channel blocker (CCB)] and amlodipine (L-type CCB) alone or in combination with the angiotensin II receptor blocker (ARB), valsartan, on blood pressure (B
Autor:
Tomoyuki Konda, Hajime Koganei, Tetsuya Ogawa, Kosaku Nitta, Shizuka Aritomi, Kazumi Niinuma, Azusa Enomoto
Publikováno v:
American journal of nephrology. 30(2)
Background: The L/N-type calcium channel blocker (CCB) cilnidipine has been demonstrated to suppress sympathetic nerve activity. In the present study, we investigated the effects of cilnidipine on the renin-angiotensin-aldosterone system (RAAS) in SH